nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—GBA2—bronchus—esophageal cancer	0.061	0.134	CbGeAlD
Miglustat—UGCG—bronchus—esophageal cancer	0.0602	0.132	CbGeAlD
Miglustat—GBA2—trachea—esophageal cancer	0.0548	0.12	CbGeAlD
Miglustat—UGCG—trachea—esophageal cancer	0.054	0.119	CbGeAlD
Miglustat—GBA2—digestive system—esophageal cancer	0.0472	0.104	CbGeAlD
Miglustat—UGCG—digestive system—esophageal cancer	0.0465	0.102	CbGeAlD
Miglustat—GBA2—lung—esophageal cancer	0.0394	0.0865	CbGeAlD
Miglustat—UGCG—lung—esophageal cancer	0.0388	0.0853	CbGeAlD
Miglustat—GBA2—lymph node—esophageal cancer	0.0269	0.0591	CbGeAlD
Miglustat—UGCG—lymph node—esophageal cancer	0.0266	0.0583	CbGeAlD
Miglustat—Memory loss—Cisplatin—esophageal cancer	0.0191	0.0615	CcSEcCtD
Miglustat—Neurological symptom—Cisplatin—esophageal cancer	0.0186	0.0598	CcSEcCtD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—BCL2—esophageal cancer	0.0129	0.0554	CbGpPWpGaD
Miglustat—Polyneuropathy—Capecitabine—esophageal cancer	0.0127	0.0409	CcSEcCtD
Miglustat—Cognitive impairment—Methotrexate—esophageal cancer	0.0118	0.038	CcSEcCtD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—MYC—esophageal cancer	0.00889	0.0381	CbGpPWpGaD
Miglustat—Disorder sight—Capecitabine—esophageal cancer	0.00871	0.028	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.0084	0.036	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00768	0.0329	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—PIK3CA—esophageal cancer	0.00755	0.0324	CbGpPWpGaD
Miglustat—Cognitive disorder—Methotrexate—esophageal cancer	0.00714	0.0229	CcSEcCtD
Miglustat—Appetite absent—Methotrexate—esophageal cancer	0.00621	0.0199	CcSEcCtD
Miglustat—Pain—Carboplatin—esophageal cancer	0.00585	0.0188	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00567	0.0243	CbGpPWpGaD
Miglustat—Coagulopathy—Capecitabine—esophageal cancer	0.00533	0.0171	CcSEcCtD
Miglustat—Memory impairment—Capecitabine—esophageal cancer	0.00529	0.017	CcSEcCtD
Miglustat—Neuropathy—Cisplatin—esophageal cancer	0.00528	0.017	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00519	0.0222	CbGpPWpGaD
Miglustat—Tingling sensation—Capecitabine—esophageal cancer	0.00516	0.0166	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00495	0.0212	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00453	0.0194	CbGpPWpGaD
Miglustat—GBA2—Metabolism—BLVRB—esophageal cancer	0.0044	0.0189	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SLC52A3—esophageal cancer	0.0044	0.0189	CbGpPWpGaD
Miglustat—Amnesia—Cisplatin—esophageal cancer	0.00435	0.014	CcSEcCtD
Miglustat—Gait disturbance—Capecitabine—esophageal cancer	0.00425	0.0136	CcSEcCtD
Miglustat—Influenza like illness—Capecitabine—esophageal cancer	0.00403	0.0129	CcSEcCtD
Miglustat—UGCG—Metabolism—BLVRB—esophageal cancer	0.00402	0.0173	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SLC52A3—esophageal cancer	0.00402	0.0173	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.00393	0.0169	CbGpPWpGaD
Miglustat—Neuropathy—Capecitabine—esophageal cancer	0.00389	0.0125	CcSEcCtD
Miglustat—GBA2—Metabolism—CA1—esophageal cancer	0.00374	0.016	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SLC10A2—esophageal cancer	0.00374	0.016	CbGpPWpGaD
Miglustat—Cramp muscle—Cisplatin—esophageal cancer	0.00368	0.0118	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.0036	0.0154	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CA1—esophageal cancer	0.00342	0.0147	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SLC10A2—esophageal cancer	0.00342	0.0147	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CA2—esophageal cancer	0.00342	0.0147	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00334	0.0143	CbGpPWpGaD
Miglustat—Libido decreased—Capecitabine—esophageal cancer	0.00325	0.0104	CcSEcCtD
Miglustat—Amnesia—Capecitabine—esophageal cancer	0.0032	0.0103	CcSEcCtD
Miglustat—GBA2—Metabolism—PLCE1—esophageal cancer	0.00318	0.0136	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ADH7—esophageal cancer	0.00318	0.0136	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00314	0.0135	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CA2—esophageal cancer	0.00313	0.0134	CbGpPWpGaD
Miglustat—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00309	0.00991	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00306	0.0131	CbGpPWpGaD
Miglustat—Pain in extremity—Capecitabine—esophageal cancer	0.00301	0.00967	CcSEcCtD
Miglustat—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00299	0.00959	CcSEcCtD
Miglustat—Migraine—Capecitabine—esophageal cancer	0.00296	0.00952	CcSEcCtD
Miglustat—UGCG—Metabolism—PLCE1—esophageal cancer	0.00291	0.0125	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ADH7—esophageal cancer	0.00291	0.0125	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00288	0.0123	CbGpPWpGaD
Miglustat—Ataxia—Capecitabine—esophageal cancer	0.00283	0.00909	CcSEcCtD
Miglustat—GBA2—Metabolism—ADH1B—esophageal cancer	0.00279	0.012	CbGpPWpGaD
Miglustat—Connective tissue disorder—Cisplatin—esophageal cancer	0.00278	0.00892	CcSEcCtD
Miglustat—Abdominal pain upper—Capecitabine—esophageal cancer	0.00275	0.00883	CcSEcCtD
Miglustat—Visual impairment—Cisplatin—esophageal cancer	0.00272	0.00875	CcSEcCtD
Miglustat—GBA2—Metabolism—TYMP—esophageal cancer	0.00267	0.0114	CbGpPWpGaD
Miglustat—Muscular weakness—Capecitabine—esophageal cancer	0.00266	0.00853	CcSEcCtD
Miglustat—Eye disorder—Cisplatin—esophageal cancer	0.00264	0.00848	CcSEcCtD
Miglustat—Abdominal distension—Capecitabine—esophageal cancer	0.00262	0.00841	CcSEcCtD
Miglustat—GBA2—Metabolism—CYP26A1—esophageal cancer	0.00259	0.0111	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ADH1B—esophageal cancer	0.00255	0.0109	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ALOX15—esophageal cancer	0.00253	0.0108	CbGpPWpGaD
Miglustat—Malnutrition—Cisplatin—esophageal cancer	0.00246	0.0079	CcSEcCtD
Miglustat—UGCG—Metabolism—TYMP—esophageal cancer	0.00244	0.0105	CbGpPWpGaD
Miglustat—Flatulence—Cisplatin—esophageal cancer	0.00242	0.00778	CcSEcCtD
Miglustat—GBA2—Metabolism—TPI1—esophageal cancer	0.00241	0.0103	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTO1—esophageal cancer	0.00241	0.0103	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CYP26A1—esophageal cancer	0.00237	0.0102	CbGpPWpGaD
Miglustat—Visual disturbance—Methotrexate—esophageal cancer	0.00237	0.0076	CcSEcCtD
Miglustat—Muscle spasms—Cisplatin—esophageal cancer	0.00237	0.0076	CcSEcCtD
Miglustat—Weight decreased—Capecitabine—esophageal cancer	0.00235	0.00756	CcSEcCtD
Miglustat—Depression—Capecitabine—esophageal cancer	0.00231	0.00743	CcSEcCtD
Miglustat—UGCG—Metabolism—ALOX15—esophageal cancer	0.00231	0.00991	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ALDOB—esophageal cancer	0.00231	0.00991	CbGpPWpGaD
Miglustat—Tremor—Cisplatin—esophageal cancer	0.0023	0.0074	CcSEcCtD
Miglustat—Ill-defined disorder—Cisplatin—esophageal cancer	0.00228	0.00733	CcSEcCtD
Miglustat—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00227	0.0073	CcSEcCtD
Miglustat—GBA2—Metabolism—GAPDH—esophageal cancer	0.00222	0.00954	CbGpPWpGaD
Miglustat—Malaise—Cisplatin—esophageal cancer	0.00222	0.00712	CcSEcCtD
Miglustat—UGCG—Metabolism—TPI1—esophageal cancer	0.0022	0.00945	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTO1—esophageal cancer	0.0022	0.00945	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CRABP1—esophageal cancer	0.0022	0.00945	CbGpPWpGaD
Miglustat—Convulsion—Cisplatin—esophageal cancer	0.00213	0.00684	CcSEcCtD
Miglustat—UGCG—Metabolism—ALDOB—esophageal cancer	0.00211	0.00906	CbGpPWpGaD
Miglustat—Ataxia—Methotrexate—esophageal cancer	0.00211	0.00677	CcSEcCtD
Miglustat—GBA2—Metabolism—GNG7—esophageal cancer	0.0021	0.00899	CbGpPWpGaD
Miglustat—Haemoglobin—Capecitabine—esophageal cancer	0.00209	0.00672	CcSEcCtD
Miglustat—Haemorrhage—Capecitabine—esophageal cancer	0.00208	0.00669	CcSEcCtD
Miglustat—Hypoaesthesia—Capecitabine—esophageal cancer	0.00207	0.00666	CcSEcCtD
Miglustat—Discomfort—Cisplatin—esophageal cancer	0.00207	0.00665	CcSEcCtD
Miglustat—Connective tissue disorder—Capecitabine—esophageal cancer	0.00205	0.00657	CcSEcCtD
Miglustat—UGCG—Metabolism—GAPDH—esophageal cancer	0.00203	0.00872	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CRABP1—esophageal cancer	0.00202	0.00865	CbGpPWpGaD
Miglustat—Visual impairment—Capecitabine—esophageal cancer	0.00201	0.00645	CcSEcCtD
Miglustat—Nervous system disorder—Cisplatin—esophageal cancer	0.00197	0.00632	CcSEcCtD
Miglustat—Thrombocytopenia—Cisplatin—esophageal cancer	0.00197	0.00631	CcSEcCtD
Miglustat—GBA2—Metabolism—ALDH2—esophageal cancer	0.00196	0.00842	CbGpPWpGaD
Miglustat—Eye disorder—Capecitabine—esophageal cancer	0.00195	0.00625	CcSEcCtD
Miglustat—UGCG—Metabolism—GNG7—esophageal cancer	0.00192	0.00822	CbGpPWpGaD
Miglustat—Anorexia—Cisplatin—esophageal cancer	0.00191	0.00615	CcSEcCtD
Miglustat—Chills—Capecitabine—esophageal cancer	0.00187	0.006	CcSEcCtD
Miglustat—GBA2—Metabolism—GSTT1—esophageal cancer	0.00187	0.00801	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP2A6—esophageal cancer	0.00185	0.00792	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.00184	0.00789	CbGpPWpGaD
Miglustat—Mental disorder—Capecitabine—esophageal cancer	0.00182	0.00586	CcSEcCtD
Miglustat—Malnutrition—Capecitabine—esophageal cancer	0.00181	0.00582	CcSEcCtD
Miglustat—Paraesthesia—Cisplatin—esophageal cancer	0.0018	0.00579	CcSEcCtD
Miglustat—UGCG—Metabolism—ALDH2—esophageal cancer	0.0018	0.00771	CbGpPWpGaD
Miglustat—Flatulence—Capecitabine—esophageal cancer	0.00179	0.00574	CcSEcCtD
Miglustat—Back pain—Capecitabine—esophageal cancer	0.00175	0.00563	CcSEcCtD
Miglustat—GBA2—Metabolism—PTGS1—esophageal cancer	0.00175	0.00751	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ENO1—esophageal cancer	0.00175	0.00751	CbGpPWpGaD
Miglustat—Decreased appetite—Cisplatin—esophageal cancer	0.00175	0.0056	CcSEcCtD
Miglustat—Muscle spasms—Capecitabine—esophageal cancer	0.00174	0.0056	CcSEcCtD
Miglustat—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00173	0.00557	CcSEcCtD
Miglustat—GBA2—Metabolism—PSME2—esophageal cancer	0.00173	0.0074	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PSME1—esophageal cancer	0.00173	0.0074	CbGpPWpGaD
Miglustat—Depression—Methotrexate—esophageal cancer	0.00172	0.00553	CcSEcCtD
Miglustat—Pain—Cisplatin—esophageal cancer	0.00172	0.00551	CcSEcCtD
Miglustat—UGCG—Metabolism—GSTT1—esophageal cancer	0.00171	0.00733	CbGpPWpGaD
Miglustat—Tremor—Capecitabine—esophageal cancer	0.0017	0.00546	CcSEcCtD
Miglustat—UGCG—Metabolism—CYP2A6—esophageal cancer	0.00169	0.00724	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.00168	0.00722	CbGpPWpGaD
Miglustat—Ill-defined disorder—Capecitabine—esophageal cancer	0.00168	0.0054	CcSEcCtD
Miglustat—Feeling abnormal—Cisplatin—esophageal cancer	0.00165	0.00531	CcSEcCtD
Miglustat—Malaise—Capecitabine—esophageal cancer	0.00164	0.00525	CcSEcCtD
Miglustat—Vertigo—Capecitabine—esophageal cancer	0.00163	0.00523	CcSEcCtD
Miglustat—UGCG—Metabolism—ENO1—esophageal cancer	0.0016	0.00687	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PTGS1—esophageal cancer	0.0016	0.00687	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PSME2—esophageal cancer	0.00158	0.00677	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PSME1—esophageal cancer	0.00158	0.00677	CbGpPWpGaD
Miglustat—Haemoglobin—Methotrexate—esophageal cancer	0.00156	0.00501	CcSEcCtD
Miglustat—Haemorrhage—Methotrexate—esophageal cancer	0.00155	0.00498	CcSEcCtD
Miglustat—Discomfort—Capecitabine—esophageal cancer	0.00153	0.0049	CcSEcCtD
Miglustat—Dry mouth—Capecitabine—esophageal cancer	0.00151	0.00485	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.00151	0.00646	CbGpPWpGaD
Miglustat—Visual impairment—Methotrexate—esophageal cancer	0.00149	0.0048	CcSEcCtD
Miglustat—GBA2—Metabolism—CYP1B1—esophageal cancer	0.00149	0.00638	CbGpPWpGaD
Miglustat—Nervous system disorder—Capecitabine—esophageal cancer	0.00145	0.00466	CcSEcCtD
Miglustat—Eye disorder—Methotrexate—esophageal cancer	0.00145	0.00465	CcSEcCtD
Miglustat—Thrombocytopenia—Capecitabine—esophageal cancer	0.00145	0.00465	CcSEcCtD
Miglustat—Asthenia—Cisplatin—esophageal cancer	0.00144	0.00463	CcSEcCtD
Miglustat—Anorexia—Capecitabine—esophageal cancer	0.00141	0.00453	CcSEcCtD
Miglustat—GBA2—Metabolism—CYP19A1—esophageal cancer	0.0014	0.006	CbGpPWpGaD
Miglustat—Chills—Methotrexate—esophageal cancer	0.00139	0.00447	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.00138	0.00591	CbGpPWpGaD
Miglustat—Diarrhoea—Cisplatin—esophageal cancer	0.00137	0.00441	CcSEcCtD
Miglustat—UGCG—Metabolism—CYP1B1—esophageal cancer	0.00136	0.00584	CbGpPWpGaD
Miglustat—Mental disorder—Methotrexate—esophageal cancer	0.00136	0.00436	CcSEcCtD
Miglustat—Malnutrition—Methotrexate—esophageal cancer	0.00135	0.00434	CcSEcCtD
Miglustat—Insomnia—Capecitabine—esophageal cancer	0.00134	0.0043	CcSEcCtD
Miglustat—Paraesthesia—Capecitabine—esophageal cancer	0.00133	0.00427	CcSEcCtD
Miglustat—Back pain—Methotrexate—esophageal cancer	0.00131	0.00419	CcSEcCtD
Miglustat—Dyspepsia—Capecitabine—esophageal cancer	0.0013	0.00418	CcSEcCtD
Miglustat—Decreased appetite—Capecitabine—esophageal cancer	0.00129	0.00413	CcSEcCtD
Miglustat—UGCG—Metabolism—CYP19A1—esophageal cancer	0.00128	0.00549	CbGpPWpGaD
Miglustat—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00128	0.0041	CcSEcCtD
Miglustat—GBA2—Metabolism—HMOX1—esophageal cancer	0.00128	0.00548	CbGpPWpGaD
Miglustat—Vomiting—Cisplatin—esophageal cancer	0.00128	0.0041	CcSEcCtD
Miglustat—Fatigue—Capecitabine—esophageal cancer	0.00128	0.0041	CcSEcCtD
Miglustat—Constipation—Capecitabine—esophageal cancer	0.00127	0.00406	CcSEcCtD
Miglustat—Pain—Capecitabine—esophageal cancer	0.00127	0.00406	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.00125	0.00537	CbGpPWpGaD
Miglustat—Ill-defined disorder—Methotrexate—esophageal cancer	0.00125	0.00402	CcSEcCtD
Miglustat—GBA2—Metabolism—ABCB1—esophageal cancer	0.00123	0.00526	CbGpPWpGaD
Miglustat—Feeling abnormal—Capecitabine—esophageal cancer	0.00122	0.00392	CcSEcCtD
Miglustat—Malaise—Methotrexate—esophageal cancer	0.00122	0.00391	CcSEcCtD
Miglustat—Vertigo—Methotrexate—esophageal cancer	0.00121	0.00389	CcSEcCtD
Miglustat—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00121	0.00389	CcSEcCtD
Miglustat—Nausea—Cisplatin—esophageal cancer	0.00119	0.00383	CcSEcCtD
Miglustat—Abdominal pain—Capecitabine—esophageal cancer	0.00117	0.00376	CcSEcCtD
Miglustat—Convulsion—Methotrexate—esophageal cancer	0.00117	0.00376	CcSEcCtD
Miglustat—UGCG—Metabolism—HMOX1—esophageal cancer	0.00117	0.00501	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.00115	0.00492	CbGpPWpGaD
Miglustat—Discomfort—Methotrexate—esophageal cancer	0.00114	0.00365	CcSEcCtD
Miglustat—UGCG—Metabolism—ABCB1—esophageal cancer	0.00112	0.00481	CbGpPWpGaD
Miglustat—Nervous system disorder—Methotrexate—esophageal cancer	0.00108	0.00347	CcSEcCtD
Miglustat—Thrombocytopenia—Methotrexate—esophageal cancer	0.00108	0.00346	CcSEcCtD
Miglustat—Asthenia—Capecitabine—esophageal cancer	0.00106	0.00341	CcSEcCtD
Miglustat—Anorexia—Methotrexate—esophageal cancer	0.00105	0.00337	CcSEcCtD
Miglustat—Diarrhoea—Capecitabine—esophageal cancer	0.00101	0.00325	CcSEcCtD
Miglustat—Insomnia—Methotrexate—esophageal cancer	0.000996	0.0032	CcSEcCtD
Miglustat—Paraesthesia—Methotrexate—esophageal cancer	0.000989	0.00318	CcSEcCtD
Miglustat—Dizziness—Capecitabine—esophageal cancer	0.000979	0.00314	CcSEcCtD
Miglustat—Dyspepsia—Methotrexate—esophageal cancer	0.00097	0.00311	CcSEcCtD
Miglustat—Decreased appetite—Methotrexate—esophageal cancer	0.000958	0.00308	CcSEcCtD
Miglustat—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000951	0.00305	CcSEcCtD
Miglustat—Fatigue—Methotrexate—esophageal cancer	0.00095	0.00305	CcSEcCtD
Miglustat—Pain—Methotrexate—esophageal cancer	0.000942	0.00303	CcSEcCtD
Miglustat—Vomiting—Capecitabine—esophageal cancer	0.000941	0.00302	CcSEcCtD
Miglustat—Headache—Capecitabine—esophageal cancer	0.000927	0.00298	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000927	0.00398	CbGpPWpGaD
Miglustat—Feeling abnormal—Methotrexate—esophageal cancer	0.000908	0.00292	CcSEcCtD
Miglustat—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000901	0.00289	CcSEcCtD
Miglustat—Nausea—Capecitabine—esophageal cancer	0.000879	0.00282	CcSEcCtD
Miglustat—Abdominal pain—Methotrexate—esophageal cancer	0.000871	0.0028	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000848	0.00364	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CREBBP—esophageal cancer	0.000819	0.00351	CbGpPWpGaD
Miglustat—Asthenia—Methotrexate—esophageal cancer	0.00079	0.00254	CcSEcCtD
Miglustat—Diarrhoea—Methotrexate—esophageal cancer	0.000754	0.00242	CcSEcCtD
Miglustat—UGCG—Metabolism—CREBBP—esophageal cancer	0.00075	0.00321	CbGpPWpGaD
Miglustat—GBA2—Metabolism—NOS3—esophageal cancer	0.000734	0.00315	CbGpPWpGaD
Miglustat—Dizziness—Methotrexate—esophageal cancer	0.000729	0.00234	CcSEcCtD
Miglustat—Vomiting—Methotrexate—esophageal cancer	0.0007	0.00225	CcSEcCtD
Miglustat—Headache—Methotrexate—esophageal cancer	0.00069	0.00222	CcSEcCtD
Miglustat—GBA2—Metabolism—PTGS2—esophageal cancer	0.000671	0.00288	CbGpPWpGaD
Miglustat—UGCG—Metabolism—NOS3—esophageal cancer	0.000671	0.00288	CbGpPWpGaD
Miglustat—Nausea—Methotrexate—esophageal cancer	0.000654	0.0021	CcSEcCtD
Miglustat—UGCG—Metabolism—PTGS2—esophageal cancer	0.000614	0.00263	CbGpPWpGaD
Miglustat—GBA2—Metabolism—EP300—esophageal cancer	0.000558	0.00239	CbGpPWpGaD
Miglustat—UGCG—Metabolism—EP300—esophageal cancer	0.00051	0.00219	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PIK3CA—esophageal cancer	0.000413	0.00177	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PIK3CA—esophageal cancer	0.000378	0.00162	CbGpPWpGaD
